FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Chlorhexidine Gluconate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 28 USDMF, 9 CEP/COS, 8 JDMF, 7 EU WC, 1 KDMF, 1 VMF, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

45 Drugs in Development

45 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

322 FDF Dossiers, 49 FDA Orange Book, 172 Europe, 69 Canada, 11 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%, SOLUTION;TOPICAL - 2%, TABLET;DENTAL - 2.5MG, SOLUTION;TOPICAL - 2%;70%, SPONGE;TOPICAL - 2%;70% (1.5ML), SPONGE;TOPICAL - 2%;70% (10.5ML), SPONGE;TOPICAL - 2%;70% (1ML), SPONGE;TOPICAL - 2%;70% (26ML), SPONGE;TOPICAL - 2%;70% (3ML), SOLUTION;TOPICAL - 61%;1%, SWAB;TOPICAL - 3.15%;70% (1.6ML), SWAB;TOPICAL - 3.15%;70% (1ML), SWAB;TOPICAL - 3.15%;70% (5.1ML), SWAB;TOPICAL - 2%;70% (0.67ML), SWAB;TOPICAL - 2%;70% (1.75ML), SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 4 SPI Pharma, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Pfanstiehl, 10 Kirsch Pharma, 4 ACG Worldwide, 18 Actylis, 1 Ashland, 23 BASF, 2 BioSpectra, 4 CD Formulation, 1 Clariant, 6 Corel Pharma Chem, 1 Esteem Industries, 4 Finar, 5 Gangwal Chemicals, 2 Gloria Interchem, 1 Ideal Cures, 3 Kerry, 1 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pluviaendo, 1 Qualicaps, 19 Roquette, 16 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

47 Topical, 37 Parenteral, 36 Solubilizers, 26 Thickeners and Stabilizers, 21 Coating Systems & Additives, 19 Film Formers & Plasticizers, 16 Fillers, Diluents & Binders, 13 Surfactant & Foaming Agents, 11 Controlled & Modified Release, 10 Taste Masking, 10 Emulsifying Agents, 8 Empty Capsules, 6 Co-Processed Excipients, 6 Rheology Modifiers, 5 Direct Compression, 4 API Stability Enhancers, 4 Granulation, 4 Chewable & Orodispersible Aids, 4 Lubricants & Glidants, 2 Disintegrants & Superdisintegrants, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 24 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 3 Regulatory FDF Prices

MARKET PLACE

34 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 1 US Exclusivities

$ Xls

Filters

SPONGE;TOPICAL - 2%;70% (1.5ML)

SPONGE;TOPICAL - 2%;70% (10.5ML)

SPONGE;TOPICAL - 2%;70% (1ML)

SPONGE;TOPICAL - 2%;70% (26ML)

SPONGE;TOPICAL - 2%;70% (3ML)

SWAB;TOPICAL - 2%;70% (0.67ML)

SWAB;TOPICAL - 2%;70% (1.75ML)

SWAB;TOPICAL - 2%;70% (5.25ML)

SOLUTION;TOPICAL - 2%

SWAB;TOPICAL - 3.15%;70% (1.6ML)

SWAB;TOPICAL - 3.15%;70% (1ML)

SWAB;TOPICAL - 3.15%;70% (5.1ML)

TABLET;DENTAL - 2.5MG

SOLUTION;TOPICAL - 61%;1%

SOLUTION;TOPICAL - 2%;70%

AEROSOL, METERED;TOPICAL - 4%

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Chlorhexidine Gluconate

Chlorhexidine Gluconate

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

53 API Suppliers

28 USDMF

9 CEP/COS

8 JDMF

7 EU WC

1 KDMF

1 VMF

18 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

45 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

322 FDF Dossiers

49 FDA Orange Book

172 Europe

69 Canada

11 South Africa

21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%

SOLUTION;TOPICAL - 2%

TABLET;DENTAL - 2.5MG

SOLUTION;TOPICAL - 2%;70%

SPONGE;TOPICAL - 2%;70% (1.5ML)

SPONGE;TOPICAL - 2%;70% (10.5ML)

SPONGE;TOPICAL - 2%;70% (1ML)

SPONGE;TOPICAL - 2%;70% (26ML)

SPONGE;TOPICAL - 2%;70% (3ML)

SOLUTION;TOPICAL - 61%;1%

SWAB;TOPICAL - 3.15%;70% (1.6ML)

SWAB;TOPICAL - 3.15%;70% (1ML)

SWAB;TOPICAL - 3.15%;70% (5.1ML)

SWAB;TOPICAL - 2%;70% (0.67ML)

SWAB;TOPICAL - 2%;70% (1.75ML)

SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

4 SPI Pharma

1 Pharm-RX Chemical

3 Boai NKY Pharmaceuticals Ltd

1 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

3 Pfanstiehl

10 Kirsch Pharma

4 ACG Worldwide

18 Actylis

1 Ashland

23 BASF

2 BioSpectra

4 CD Formulation

1 Clariant

6 Corel Pharma Chem

1 Esteem Industries

4 Finar

5 Gangwal Chemicals

2 Gloria Interchem

1 Ideal Cures

3 Kerry

1 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

1 Lubrizol Life Science Health

3 Microlex e.U

1 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nomisma Healthcare

1 Novo Excipients

1 Pluviaendo

1 Qualicaps

19 Roquette